Can lissencephaly present with seizures in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lissencephaly and Seizures in Children

Yes, lissencephaly characteristically presents with seizures in children, with nearly all patients developing drug-resistant epilepsy, typically beginning within the first 6 months of life. 1, 2

Clinical Presentation

Seizures are a hallmark feature of lissencephaly, occurring in virtually all affected children:

  • All but two patients in a cohort of 47 genetically confirmed lissencephaly cases developed epilepsy 2
  • Median age at seizure onset is 6 months (range: 2.1-42.0 months) 2
  • 82% of patients with LIS1-associated lissencephaly experience seizure onset within the first 6 months of life 1

Seizure Types and Evolution

The epileptogenic phenotype in lissencephaly follows a characteristic pattern:

Early Presentation

  • Infantile spasms (epileptic spasms) are the initial seizure type in 70% of patients 2
  • These typically begin in the first year of life and represent the most common presenting seizure type 1, 3

Later Evolution

  • The seizure phenotype becomes more variable later in infancy and childhood 1
  • Generalized tonic-clonic seizures emerge as the predominant seizure type as children age 1
  • Focal seizures of various forms also occur 1

Associated Clinical Features

Children with lissencephaly present with a constellation of findings beyond seizures:

  • Severe psychomotor retardation and developmental delay 1, 2, 3
  • Feeding and swallowing difficulties 3
  • Muscle tone abnormalities: early hypotonia progressing to limb hypertonia 3
  • Microcephaly 4

Neuroimaging Correlation

MRI is the diagnostic modality of choice for identifying lissencephaly and associated malformations of cortical development 5:

  • Lissencephaly is characterized by absent gyri (agyria) or broad gyri (pachygyria) with abnormally thick cortex 5
  • The cortex appears thickened with four disorganized layers rather than six normal layers 3
  • Associated findings may include corpus callosum dysgenesis and cerebellar/brainstem hypoplasia 4

Prognostic Implications

The presence of epileptic spasms carries significant prognostic weight:

  • Patients presenting without epileptic spasms are significantly more likely to reach developmental milestones compared to those with spasms 2
  • This underscores the importance of early recognition and aggressive treatment of infantile spasms in lissencephaly 2

Treatment Considerations

Epilepsy in lissencephaly is characteristically drug-resistant 1, 2:

For Infantile Spasms

  • Standard hormonal therapy (ACTH or corticosteroids) and/or vigabatrin achieve seizure control in 47% of patients 2

For Later Seizures

  • Valproic acid and lamotrigine are most effective, achieving seizure freedom in 20% of patients 2
  • Lamotrigine and valproate show good or partial response rates in 88-100% of patients 1
  • Vigabatrin and phenobarbital are also effective second-line options 1, 2

Clinical Pitfall

Do not delay neuroimaging in children presenting with early-onset seizures, developmental delay, and feeding difficulties, as this constellation strongly suggests a malformation of cortical development requiring MRI for diagnosis 5, 2. The earlier the diagnosis, the more rapidly appropriate antiseizure management can be initiated, which may improve developmental outcomes 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.